[COLL] Collegium Pharmaceutical, Inc.

Overview

Type of security:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 16.35 Change: 0.79 (5.08%)
Ext. hours: Change: 0 (0%)

chart COLL

Refresh chart

See how to gain 20% in 14 sec with TrendsInvesting

Technical Data
High 52 week28.29 Low 52 week12.51 Last close12.51 Last change-1.26%
RSI28.45 Average true range0.84 Simple moving average 20 days-10.85% Simple moving average 50 days-18.16%
Simple moving average 200 days-22.89%
Performance Data
Performance Week-11.4% Performance Month-8.08% Performance Quart-15.42% Performance Half-27.06%
Performance Year-49.06% Performance Year-to-date-27.14% Volatility daily3.4% Volatility weekly7.61%
Volatility monthly15.59% Volatility yearly53.99% New High New Low

News

2019-06-19 10:41:00 | Hedge Funds Have Never Been This Bullish On Collegium Pharmaceutical Inc COLL

2019-05-29 08:00:00 | Collegium to Present at Upcoming Investor Conferences

2019-05-09 22:03:24 | Collegium Pharmaceutical, Inc. COLL Q1 2019 Earnings Call Transcript

2019-05-09 13:53:55 | Were Hedge Funds Right About Dumping Collegium Pharmaceutical Inc COLL ?

2019-05-09 11:24:10 | Assertio Therapeutics, Inc ASRT Q1 2019 Earnings Call Transcript

2019-05-09 00:06:24 | Edited Transcript of COLL earnings conference call or presentation 8-May-19 8:30pm GMT

2019-05-08 17:45:09 | Collegium Pharmaceutical COLL Reports Q1 Loss, Tops Revenue Estimates

2019-05-08 16:37:31 | Collegium Pharmaceutical: 1Q Earnings Snapshot

2019-05-08 16:01:00 | Collegium Reports First Quarter 2019 Financial Results

2019-05-06 11:54:03 | Assertio Therapeutics ASRT to Post Q1 Earnings: What's Up?

2019-05-05 09:19:00 | 2 Big Biotech Stock Upgrades: Can They Reach These Targets?

2019-05-01 10:33:02 | Collegium Pharmaceutical COLL Expected to Beat Earnings Estimates: Should You Buy?

2019-04-30 16:01:00 | Collegium to Participate in Upcoming Investor Conferences

2019-04-24 16:01:00 | Collegium to Host Conference Call to Discuss First Quarter 2019 Financial Results and Provide Corporate Update

2019-04-02 08:00:00 | Collegium Appoints Richard Malamut, M.D., as Chief Medical Officer

2019-04-01 08:00:00 | Collegium to Present at Upcoming Investor Conferences

2019-03-31 09:45:55 | Read This Before Buying Collegium Pharmaceutical, Inc. NASDAQ:COLL Shares

2019-03-25 09:00:01 | Collegium Pharmaceutical COLL Upgraded to Buy: What Does It Mean for the Stock?

2019-03-06 23:49:36 | Assertio Therapeutics, Inc ASRT Q4 2018 Earnings Conference Call Transcript

2019-02-28 03:03:01 | Edited Transcript of COLL earnings conference call or presentation 27-Feb-19 9:30pm GMT

2019-02-27 19:14:44 | Collegium Pharmaceutical Inc COLL Q4 2018 Earnings Conference Call Transcript

2019-02-27 16:01:00 | Collegium Reports Fourth-Quarter and Full-Year 2018 Financial Results

2019-02-20 10:31:03 | Collegium Pharmaceutical COLL May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

2019-02-15 09:30:02 | ASRT or COLL: Which Is the Better Value Stock Right Now?

2019-02-13 08:40:19 | Collegium to Host Conference Call to Discuss Fourth Quarter 2018 Financial Results and Provide Corporate Update

2019-02-12 14:03:26 | Breakeven On The Horizon For Collegium Pharmaceutical, Inc. NASDAQ:COLL

2019-01-30 09:30:02 | ASRT vs. COLL: Which Stock Should Value Investors Buy Now?

2019-01-17 07:20:00 | Report: Developing Opportunities within Enterprise Products Partners, Antero Midstream Partners LP, Integrated Device Technology, Collegium Pharmaceutical, GAIN Capital, and United Technologies — Future Expectations, Projections Moving into 2019

2019-01-14 09:30:02 | ASRT vs. COLL: Which Stock Should Value Investors Buy Now?

2019-01-07 08:00:00 | Collegium Provides Full-Year 2019 Financial Guidance

2018-12-19 23:43:22 | Do Hedge Funds Love Collegium Pharmaceutical Inc COLL?

2018-12-11 14:31:04 | How Financially Strong Is Collegium Pharmaceutical, Inc. NASDAQ:COLL?

2018-11-26 16:44:34 | Collegium Pharmaceutical, Inc. NASDAQ:COLL: Are Hedge Funds Right About This Stock?

2018-11-12 07:24:14 | Collegium to Present at Upcoming Investor Conferences

2018-11-08 21:16:22 | Edited Transcript of COLL earnings conference call or presentation 8-Nov-18 9:30pm GMT

2018-11-08 19:25:12 | Collegium Pharmaceutical COLL Reports Q3 Loss, Lags Revenue Estimates

2018-11-08 18:21:29 | Collegium Pharmaceutical: 3Q Earnings Snapshot

2018-11-08 16:05:00 | Collegium Reports Third Quarter Financial Results

2018-11-08 08:04:01 | Collegium Pharmaceutical Q3 Earnings Preview

2018-11-01 11:28:03 | Collegium Pharmaceutical COLL May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

2018-10-29 08:00:00 | Collegium Announces Publication of Data on Oral Abuse Potential of Xtampza ER

2018-10-18 08:00:00 | Report: Exploring Fundamental Drivers Behind Continental Building Products, Hornbeck Offshore Services, Digi International, Triple-S Management, Collegium Pharmaceutical, and Cardiovascular — New Horizons, Emerging Trends, and Upcoming Developments

2018-10-17 08:30:43 | Collegium to Host Conference Call to Discuss Third Quarter 2018 Financial Results and Provide Corporate Update

2018-09-28 14:16:49 | Collegium to Present at Upcoming Investor Conference

2018-09-04 10:01:14 | Collegium Announces Scientific Presentations at PAINWeek 2018 Meeting

2018-08-31 13:27:06 | Surge in Xtampza Sales Bodes Well for Collegium Pharmaceutical

2018-08-31 13:27:06 | What Collegium Pharmaceutical’s Valuation Trend Indicates

2018-08-31 13:27:04 | How Is Insys Therapeutics Positioned in H2 2018?

2018-08-24 07:30:00 | Report: Exploring Fundamental Drivers Behind Fiesta Restaurant Group, Emerge Energy Services LP, Collegium Pharmaceutical, Cutera, Resources Connection, and Spark Therapeutics — New Horizons, Emerging Trends, and Upcoming Developments

2018-08-23 23:45:35 | Edited Transcript of COLL earnings conference call or presentation 8-Aug-18 8:30pm GMT